Hierarchy of Physiological Responses to Hypoglycemia: Relevance to Clinical Hypoglycemia in Type I (Insulin Dependent) Diabetes Mellitus*
The DOI matches its Crossref record.
Abstract
Hypoglycemia elicits a characteristic sequence of responses in healthy humans. These responses (and their arterialized venous glycemic thresholds) include: 1) Decreased insulin secretion (approximately 4.5 mmol/L). 2) Increased glucose counterregulatory hormone (glucagon, epinephrine, growth hormone and cortisol) secretion (approximately 3.6-3.8 mmol/L). 3) Symptoms of hypoglycemia (approximately 3.0 mmol/L). 4) Cognitive dysfunction (approximately 2.6 mmol/L). Thus, insulin secretion decreases as plasma glucose levels fall within the physiological range, and counterregulatory hormone secretion increases as plasma glucose levels fall just below the physiological range at substantially higher glucose levels than those required to produce symptoms and impair cognitive function. These data are entirely consistent with the body of evidence that insulin, glucagon and epinephrine stand high in the hierarchy of redundant glucoregulatory factors that prevent, as well as correct, hypoglycemia. When the same methods are used, these thresholds are remarkably reproducible from laboratory to laboratory. Nonetheless, the glycemic thresholds are dynamic rather than static. They vary in relation to recent antecedent glycemia. For example, lower plasma glucose concentrations are required to elicit autonomic, including epinephrine, and symptomatic responses in patients with well controlled IDDM, a phenomenon best attributed to recent antecedent iatrogenic hypoglycemia. This is the basis of the…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cited by
Association of Hypoglycemia and Cardiac Ischemia
Desouza, C., Salazar, H., Cheong, B., Murgo, J., & Fonseca, V. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1485 · Cited by 406
Wheeler, M. J., Dempsey, P. C., Grace, M. S., Ellis, K. A., Gardiner, P. A., Green, D. J., & Dunstan, D. W. (2017) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.04.001 · Cited by 183
“As glucose levels fall, there is a decrease in secretion of insulin and increased secretion of glucagon and epinephrine to increase glucose levels [26].”
BackgroundSweet talk in the brain: Glucosensing, neural networks, and hypoglycemic counterregulation
Watts, A. G., & Donovan, C. M. (2010) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.10.006 · Cited by 175
“Glucocorticoids are important metabolic hormones for the later stages of the counterregulatory response [28].”
InfluentialPaty, B. W., Ryan, E. A., Shapiro, A. M. J., Lakey, J. R. T., & Robertson, R. P. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3428 · Cited by 154
“Typically, patients with long-standing type 1 diabetes have severely impaired hormonal counterregulation (2,5).”
BackgroundGhrelin Is Not Necessary for Adequate Hormonal Counterregulation of Insulin-Induced Hypoglycemia
Lucidi, P., Murdolo, G., Di Loreto, C., De Cicco, A., Parlanti, N., Fanelli, C., Santeusanio, F., Bolli, G. B., & De Feo, P. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2911 · Cited by 146
“Cortisol and GH do not play a role in defense against acute hypoglycemia (15,19) but are important counterregulatory hormones in prolonged hypoglycemia because they increase hepatic glucose production and decrease peripheral glucose utilization (10,11,15).”
BackgroundNeural pathways that control the glucose counterregulatory response
Verberne, A. J. M., Sabetghadam, A., & Korim, W. S. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00038 · Cited by 139
Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach
Kedia (2011) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s20633 · Cited by 131
“Hypoglycemia is associated with significant morbidity: physical (such as palpitations, sweating, and neurological impairments) as well as psychological (such as mood disturbance and generalized worry and fear of hypoglycemia); reductions in quality of life; and risk of death,(9) with 2%–6% of all deaths in people with…”
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1
DeAngelis, A. M., Heinrich, G., Dai, T., Bowman, T. A., Patel, P. R., Lee, S. J., Hong, E., Jung, D. Y., Aßmann, A., Kulkarni, R. N., et al. (2008) · Diabetes · doi:10.2337/db08-0379 · Cited by 123
“In addition to glucagon, epinephrine, growth hormone, and cortisol also work as fail safe mechanisms to ensure glucose levels remain above appropriate levels (Cryer 1997).”
BackgroundDoes insulin detemir have a role in reducing risk of insulin‐associated weight gain?
Hermansen, K., & Davies, M. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00665.x · Cited by 100
Peripheral and Central Glucose Sensing In Hypoglycemic Detection
Donovan, C. M., & Watts, A. G. (2014) · Physiology · doi:10.1152/physiol.00069.2013 · Cited by 86
“ducing uptake by nonneuronal tissues (20).”
Altered Neuroendocrine Sleep Architecture in Patients With Type 1 Diabetes
Jauch-Chara, K., Schmid, S. M., Hallschmid, M., Born, J., & Schultes, B. (2008) · Diabetes Care · doi:10.2337/dc07-1986 · Cited by 78
Ionut, V., Hücking, K., Liberty, I. F., & Bergman, R. N. (2005) · Diabetologia · doi:10.1007/s00125-005-1709-3 · Cited by 77
“In our study, the hypoglycaemic threshold of about 4 mmol/l that has been established for counterregulation [42] was only reached in one animal, while the average values, though below basal, remained above the threshold.”
BackgroundMobbs, C. V., Isoda, F., Makimura, H., Mastaitis, J. W., Mizuno, T. M., Shu, I.-W., Yen, K., & Yang, X.-J. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.04.005 · Cited by 82
Wagner, V. M., Grabert, M., & Holl, R. W. (2004) · European Journal of Pediatrics · doi:10.1007/s00431-004-1560-4 · Cited by 66
“unawareness and defective counter regulation [7, 9,23].”
The dawn phenomenon and the Somogyi effect - two phenomena of morning hyperglycaemia.
Rybicka, M., Krysiak, R. G., & Okopień, B. (2011) · PubMed · Cited by 54
Chan, O., Paranjape, S., Czyzyk, D., Horblitt, A., Zhu, W., Ding, Y., Fan, X., Seashore, M., & Sherwin, R. (2011) · Diabetes · doi:10.2337/db10-1579 · Cited by 54
“The brain, and particularly the ventromedial hypothalamus (VMH), plays a crucial role in sensing hypoglycemia and initiating the physiological counterregulatory responses that rapidly correct it (3–6), namely the release of glucagon and epinpehrine (7).”
Kale, A. Y., Paranjape, S., & Briski, K. P. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.02.041 · Cited by 56
Lobmann, R. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2758 · Cited by 48
Hypoglycemia associated autonomic failure
Diedrich, L., Sandoval, D. A., & Davis, S. N. (2002) · Clinical Autonomic Research · doi:10.1007/s10286-002-0035-9 · Cited by 49
“Different definitions for a glycemic threshold exist [37,38].”
Fang, C., Li, B.-G., Sun, X., & Hasselgren, P.-O. (2000) · Endocrinology · doi:10.1210/endo.141.8.7593 · Cited by 46
“One of the side-effects of treatment with IGF-I is hypoglycemia (25); and because hypoglycemia has a catabolic effect in skeletal muscle, either as a direct effect or secondary to release of catabolic hormones [in particular, epinephrine and glucagon (26, 27)], it is possible that the lack of effect of the hormone on…”
Hypoglycemia in Type 1 Diabetes Mellitus: Pathophysiology and Prevention
Dagogo-Jack, S. (2004) · Treatments in Endocrinology · doi:10.2165/00024677-200403020-00004 · Cited by 40
Feeding and neuroendocrine responses after recurrent insulin-induced hypoglycemia
Sanders, N. M., Figlewicz, D. P., Taborsky, G. J., Wilkinson, C. W., Daumen, W., & Levin, B. E. (2006) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.01.007 · Cited by 41
Role of the hypothalamus in mediating protective effects of dietary restriction during aging
Dacks, P. A., Moreno, C. L., Kim, E. S., Marcellino, B. K., & Mobbs, C. V. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.12.001 · Cited by 39
Korim, W. S., Llewellyn‐Smith, I. J., & Verberne, A. J. M. (2015) · Endocrinology · doi:10.1210/en.2015-1712 · Cited by 39
Khan, A. M., Kaminski, K. L., Sanchez-Watts, G., Ponzio, T. A., Kuzmiski, J. B., Bains, J. S., & Watts, A. G. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4785-11.2011 · Cited by 37
“The physiological consequences of these two challenges have been discussed previously by Cryer (1997) and Ritter et al. (2001).”
Davey, R. J., Jones, T. W., & Fournier, P. A. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400620 · Cited by 36
Jensen, V. F. H., Bøgh, I. B., & Lykkesfeldt, J. (2014) · Journal of Neuroendocrinology · doi:10.1111/jne.12133 · Cited by 43
Central Nervous Insulin Signaling in Sleep-Associated Memory Formation and Neuroendocrine Regulation
Feld, G. B., Wilhem, I., Benedict, C., Rüdel, B., Klameth, C., Born, J., & Hallschmid, M. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.312 · Cited by 36
“8 mmol/l where hormonal counter regulatory responses including an increase in growth hormone release are elicited (Cryer, 1997).”
BackgroundInfluentialMobbs, C. V., Mastaitis, J. W., Zhang, M., Isoda, F., Cheng, H., & Yen, K. (2006) · KARGER eBooks · doi:10.1159/000096555 · Cited by 44
Control of Glucose Production in vivo by Insulin and Glucagon
Cherrington, A. D. (2001) · Comprehensive Physiology · doi:10.1002/cphy.cp070225 · Cited by 29
“Initially it inhibits endogenous insulin secretion and impairs glucagon release (34).”
InfluentialFasting blood glucose and HbA1c in children with ADHD
Lindblad, F., Eickhoff, M. E., Forslund, A. H., Isaksson, J., & Gustafsson, J. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.01.028 · Cited by 22
“While insulin decreases levels of blood glucose, four hormones work together to prevent or correct hypoglycemia with the main aim of protecting the requirements of the brain (Cryer, 1997).”
BackgroundBorm, K., Slawik, M., Beuschlein, F., Seiler, L., Flohr, F., Berg, A., Koenig, A., & Reincke, M. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01992 · Cited by 26
Otto, E., Semotok, C., Andrysek, J., & Basir, O. (2000) · Diabetes Technology & Therapeutics · doi:10.1089/15209150050501989 · Cited by 24
Chantzichristos, D., Eliasson, B., & Johannsson, G. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0052 · Cited by 21
Farhat, R., Aiken, J., D'Souza, N. C., Appadurai, D., Hull, G., Simonson, E., Liggins, R. T., Riddell, M. C., & Chan, O. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14652 · Cited by 27
“In response to hypoglycaemia, the secretion of glucagon stands near the top of a hierarchy of counterregulatory hormone responses that help to correct falling blood glucose levels.(2,3)”
BackgroundResultModulation of Food Intake by Glucose in Patients With Type 2 Diabetes
Schultes, B., Peters, A., Hallschmid, M., Benedict, C., Merl, V., Oltmanns, K. M., Born, J., Fehm, H. L., & Kern, W. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2884 · Cited by 22
“Support for this view derives from the observation that the glycemic thresholds for symptomatic perceptions of hypoglycemia are frequently shifted toward lower levels in type 1 diabetic patients compared with healthy subjects (34), whereas those in type 2 diabetic patients are, on the contrary, shifted toward higher l…”
BackgroundPathophysiology and management of hypoglycemia in diabetes
RANGEL, E. S., Deajon-Jackson, J. D., & Hwang, J. J. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14904 · Cited by 21
Hypoglycaemia: Its pathophysiology in insulin treated diabetes and hypoglycaemia unawareness
Heller, S. R. (2011) · The British Journal of Diabetes · doi:10.1177/1474651410397248 · Cited by 15
Foster, N. N., Azam, S., & Watts, A. G. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00042.2016 · Cited by 12
Insulin Sensitively Controls the Glucagon Response to Mild Hypoglycemia in the Dog
Igawa, K., Mugavero, M., Shiota, M., Neal, D. W., & Cherrington, A. D. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3033 · Cited by 14
“This result confirms that insulin secretion is very sensitively suppressed in response to a declining plasma glucose level, in agreement with earlier data (2,3,6).”
BackgroundResultSvensson, C. H., Henriksen, M. M., Thorsteinsson, B., & Pedersen‐Bjergaard, U. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0216 · Cited by 13
Rapid reconstitution packages (RRPs) for stable storage and delivery of glucagon
D’hers, S., Vazquez, A. N. A., Gurman, P., & Elman, N. M. (2019) · Drug Delivery and Translational Research · doi:10.1007/s13346-019-00615-4 · Cited by 10
Dufrane, D., Maillart, J., Aouassar, N., Goebbels, R., Guiot, Y., & Gianello, P. (2009) · Xenotransplantation · doi:10.1111/j.1399-3089.2009.00530.x · Cited by 11
Leinwand, B., Johnsrud, M. T., Nguyen, A. P., Meyer, J. H., & Johnson, K. (2020) · Journal of Medical Economics · doi:10.1080/13696998.2020.1742131 · Cited by 9
Kale, A. Y., Paranjape, S., & Briski, K. P. (2006) · Experimental Brain Research · doi:10.1007/s00221-006-0614-4 · Cited by 10
“and release of intermediary metabolic substrates, and by inhibiting glucose uptake by muscle and adipose tissues (Boyle and Cryer 1991; Mitrakou et al. 1991; Cryer 1997 ).”
BackgroundWilliams, E. D., Rogers, S. C., Zhang, X., Azhar, G., & Wei, J. Y. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.08.002 · Cited by 9
“A significant factor that contributes to the age-associated increase in cardiovascular disease is impaired glycemic control (insulin resistance) in the elderly (Cryer, 1997).”
Hypoglycaemia Unawareness: Causes, Consequences and Treatment
MacLeod, K. M. (2000) · Journal of the Royal College of Physicians of London · doi:10.1016/s0035-8819(25)01530-2 · Cited by 10
Xu, Y., & Tong, Q. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.09.027 · Cited by 7
Kale, A. Y., Paranjape, S., & Briski, K. P. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.07.013 · Cited by 7
“Recurrent insulin-induced hypoglycemia (RIIH) results in glucose counterregulatory dysfunction (Cryer, 1997; Cryer and Polonsky, 1997), coincident with diminished neuronal activation within characterized components of the central circuitry that regulates energy homeostasis, including the lateral…”
BackgroundOishi, K., Ohkura, N., & Ishida, N. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01980.x · Cited by 7
Regulation of Peripheral Metabolism by Substrate Partitioning in the Brain
Moreno, C. L., Yang, L. C., Dacks, P. A., Isoda, F., Poplawski, M. M., & Mobbs, C. V. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.11.007 · Cited by 8
“Nutritional deprivation also produces a characteristic set of neuroendocrine “counterregulatory” responses to preserve nutritional resources, including reduction of reproductive hormones [23], reduced thyroid hormone [24], reduced IGF-1 [25], and increased glucocorticoids as well as glucagon, and epinephrine [26-29].”
BackgroundMcCarthy, O. M., Pitt, J. P., Churm, R., Dunseath, G. J., Jones, C., Bally, L., Nakas, C. T., Deere, R., Eckstein, M. L., Bain, S. C., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001577 · Cited by 8
Nagy, I., Németh, J., & Laszik, Z. G. (2000) · Pharmacological Research · doi:10.1006/phrs.1999.0565 · Cited by 6
Hemmings, S. J., & Wilson, T. R. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1024973908194 · Cited by 6
“The liver plays a central role in the maintenance of glucose balance and catecholamine-mediated hepatic alterations in glucose metabolism are critically involved in glucocounterregulation against hypoglycemia [11, 12 ].”
BackgroundInfluentialEndogenous Metabolic Disorders
Ferrante, M. A. (2007) · Elsevier eBooks · doi:10.1016/b978-141603618-0.10038-4 · Cited by 6
Considerations for Successful Encapsulated β-Cell Therapy
Thanos, C. G., Gaglia, J. L., & Pagliuca, F. W. (2017) · Molecular and translational medicine · doi:10.1007/978-3-319-57153-9_2 · Cited by 12
“In clinical practice, approximately 90% of all patients self-administering insulin have experienced some degree of hypoglycemia [3].”
BackgroundEffect of Near Physiologic Insulin Therapy on Hypoglycemia Counterregulation in Type-1 Diabetes
Bischof, M. G., Bernroider, E., Ludwig, C., Kurzemann, S., Kletter, K., Waldhäusl, W., & Roden, M. (2001) · Hormone Research in Paediatrics · doi:10.1159/000048111 · Cited by 6
Tapia, G. P., Agostinelli, L. J., Chenausky, S. D., Padilla, J. V. S., Navarro, V. I., Alagh, A., Si, G., Thompson, R. H., Balivada, S., & Khan, A. M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072483 · Cited by 5
“Glucose counterregulatory mechanisms defend the body against precipitous drops in blood sugar by increasing glucagon and reducing insulin secretion from pancreatic α and β cells, respectively, and by increasing epinephrine release from the adrenal medulla [6].”
BackgroundThe Impact of Type 1 Diabetes on the Physiological Responses to Exercise
Riddell, M. C. (2012) · Springer eBooks · doi:10.1007/978-0-85729-754-9_2 · Cited by 7
“For example, [ 6 ] a slight decrease in glycemia from normal (normal being ~90 mg/dL or 5 mmol/L) lowers insulin secretion and activates the release of various counterregulatory hormones including glucagon, catecholamines, growth hormone, and cortisol in a stepwise and hierarchical fashion [ 7 ] .”
BackgroundPsychische Störungen und internistische Erkrankungen
Hewer, W. (1999) · Springer eBooks · doi:10.1007/978-3-642-60175-0_13 · Cited by 5
Glucagon: Are we missing a (life‐saving) trick?
Niessen, S. (2012) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/j.1476-4431.2012.00809.x · Cited by 4
Hirata's disease (insulin autoimmune syndrome) following envenomation by a common krait
Senthilkumaran, S., Miller, S. W., Williams, H. F., Thirumalaikolundusubramanian, P., Vaiyapuri, S., & Patel, K. (2022) · Toxicon · doi:10.1016/j.toxicon.2022.09.009 · Cited by 3
Using Continuous Glucose Monitoring for Patients with Fasting Hyperglycemia
Zhou, J. (2018) · Springer eBooks · doi:10.1007/978-981-10-7074-7_14 · Cited by 2
Where’s Waldo? Extrahepatic Site Options for Islet Transplantation
Coughlan, A., McEachron, K. R., Skube, M. E., Muratore, S. L., Bellin, M. D., & Beilman, G. J. (2019) · OBM Transplantation · doi:10.21926/obm.transplant.1901042 · Cited by 3
Hypoglycemia as a Pathological Result in Medical Praxis
Bjelaković, G., Stojanović, I. R., Jevtović−Stoimenov, T., Saranac, L., Bjelakovic, B. B., Pavlovic, D., Kocic, G. M., & Bjelakovic, B. B. (2011) · InTech eBooks · doi:10.5772/24754 · Cited by 2
Role of Postabsorptive Endocrine Factors on Human Feeding and Regulation of Body Adiposity
Teff, K. L., & KAPADIA, C. R. (2008) · CRC Press eBooks · doi:10.1201/9781420047844.ch12 · Cited by 1
Toxicity of Over-the-Counter and Oral Hypoglycemic Agents
Mannix, R., & Ewald, M. B. (2007) · Elsevier eBooks · doi:10.1016/b978-032303004-5.50183-6 · Cited by 1
Hyperglycemia should be Avoided in Critical Illness and the Postoperative Period
Muthusamy, K., & Miles, J. M. (2011) · Wiley eBooks · doi:10.1002/9781444340280.ch15 · Cited by 1
Yuen, K. C. J., Amin, R., Cook, M. B., Rhoads, S. A., & Cook, D. M. (2008) · Hormone Research in Paediatrics · doi:10.1159/000113024 · Cited by 2
Mental Disorders and Internal Medicine
Hewer, W. (2001) · Springer eBooks · doi:10.1007/978-3-642-59519-6_78 · Cited by 1
Robinson, R., & Paulose, C. S. (2007) · Dyuthi Digital Repository (Cochin University of Science and Technology)
Hypoglycemia and Hypoglycemia Unawareness During and Following Exercise
Younk, L. M., & Davis, S. N. (2012) · Springer eBooks · doi:10.1007/978-0-85729-754-9_6
Chronic unstable diabetes and hypoglycaemia
Heller, S. R. (2004) · CRC Press eBooks · doi:10.3109/9780203640562-8
The preproglucagon derived peptides and energy homeostasis
Parker, J. (2013) · doi:10.25560/10956
Scott, S. N., Riddell, M. C., & Yardley, J. E. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-030-33376-8_25
Ryan, C. M. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50102-5
Diabetes Management in Patients with Critical and Non‐Critical Illness
Muthusamy, K., Grdinovac, K., & Miles, J. M. (2021) · Wiley eBooks · doi:10.1002/9781119603207.ch20
Metadata
- Authors
- Cryer, P.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Cryer, P.
- Venue
- Hormone and Metabolic Research
- Publisher
- Georg Thieme Verlag KG
- Published
- 1997-03
- Volume
- 29
- Issue
- 03
- Pages
- 92-96
- ISSN
- 0018-5043 (ISSN-L)
- 1439-4286
- OpenAlex
- W2131006503
- Cited by
- 78
- References
- 0
- Citations by year
- 2023: 1 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 3 · 2013: 2 · 2012: 4
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hormone and Metabolic Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01dk044235-04)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK027085, R01 DK-44235)
- National Center for Research Resources (M01RR000036)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- hypoglycemia, type 1 diabetes, glucose counterregulation, insulin secretion, glucagon, epinephrine, growth hormone, cortisol, hypoglycemia unawareness, iatrogenic hypoglycemia, cognitive impairment, autonomic responses
- MeSH terms
- Diabetes Mellitus, Type 1, Epinephrine, Glucagon, Humans, Hypoglycemia, Insulin, Perception
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.